Seagen Inc - Company Profile
Powered by
All the data and insights you need on Seagen Inc in one report.
- Save hours of research time and resources with
our up-to-date Seagen Inc Strategy Report
- Understand Seagen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Seagen Inc (Seagen), formerly Seattle Genetics Inc, is a biotechnology company that focuses on the discovery, development, and commercialization of monoclonal antibody-based drugs for the treatment of cancer. Proprietary technology, strong collaborations, and lead product Adcetris are the major strengths of the company, even as legal proceedings is an area for concern. However, the company could benefit from market potential of Hodgkin Lymphoma, business combination with Pfizer, regulatory approvals and strategic agreements. Nevertheless, its performance could be affected by competitive environment, dependence on third parties and stringent government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer